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In addition to being the major cause of non-mela­
noma skin cancer, the ultraviolet radiation (UVR) 
present in sunlight is a potent immunosuppressive 
agent. Indeed, studies with mice and humans have 
indicated that the immune suppression induced by 
UVR is a risk factor for skin cancer development. 
These observations gave rise to the discipline of 
photoimmunology, which studies the interaction of 
T he ultraviolet radiation (UVR) present in sunlight has the potential to affect adversely human health and well being . In addition to being the major cause of non-melanoma skin cancer, UVR also induces sun­bum and erythema, promotes premature aging of the 
skin, causes ocular damage, including keratitis and cataracts, dam­
ages immune competent cells within the skin, and induces systemic 
immune suppression. Although scientists and physicians have rec­
ognized for almost 100 years that UVR induces skin cancer, the 
realization that UVR alters the immune response became apparent 
during the work of Kripke, who was studying the biology of 
UV-induced skin cancer in mice . Unlike most murine tumors, the 
UV-induced skin tumors failed to grow progressively when trans­
planted into normal syngeneic recipient mice. These "regressor" 
tumors would only grow when transplanted into an immunocom­
promised host, suggesting that the UV -induced tumors were highly 
antigenic and were rejected by the immune response of the normal 
mice. How then did these highly antigenic tumors escape the 
immune response in the UV -irradiated autochthonous host? Sub­
sequent studies by Kripke and colleagues and Daynes and co­
workers (reviewed in [1,2]) demonstrated that exposing mice to 
subcarcinogenic doses of UV radiation suppresses cell mediated 
immunity by inducing the production of antigen-specific suppressor 
T cells that transferred the suppressive state to normal recipient 
mice. Moreover, these suppressor T cells were shown to be 
involved in the development of the primary tumor in the UV­
irradiated animals. Thus, these studies demonstrated that in addi­
tion to being carcinogenic, UVR is also immunosuppressive, and 
the ability ofUVR to suppress immunity is associated with its ability 
to induce skin cancer in mice. It is important to note that more 
recent studies with biopsy-proved skin cancer patients have also 
suggested the immune suppression induced by UVR is a risk factor 
for skin cancer development in humans [3]. 
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electromagnetic radiation, primarily UVB (280-320 
nm) light, with the immune system. The focus of this 
paper will be to review recent studies designed to 
unravel the mechanisms through which UVR sup­
presses immune reactivity. Particular emphasis is 
placed on the effects ofUVR on antigen presentation. ' 
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The association between skin cancer induction and immune 
suppression has been a driving force behind the efforts of many to 
understand the mechanisms involved in the induction of immune 
suppression by UVR. The focus of this report will be to review 
recent efforts to unravel the pathways by which UVR depresses the 
immune response. 
MODULATION OF ANTIGEN-PRESENTING CELL (APC) 
FUNCTION BY UVR IS A KEY TO THE 
INDUCTION OF NON-RESPONSIVENESS 
Effects of UVR on APe Populations in the Skin: Direct 
Effects ofUV Exposure The target ofUVR is the skin, and one 
of the first hints that UV exposure was altering APC function in vivo 
came from the work of Toews et al [4], who examined the effect 
of UV radiation on the epidermal APC, the Langerhans cell 
(LC). In normal skin, LC form a dendritic network of cells through 
the epidermis . Presumably one function of these cells is to trap 
antigen, migrate to the regional lymph nodes, and present the 
antigen to T cells [5]. Toews et al demonstrated that UVR alters 
the morphology of the epidermal LC, the dendritic processes 
were destroyed, and fewer cells within the irradiated epidermis 
stained for LC markers (major histocompatibility comp lex (MHC) 
class II antigen and ATPase). In contrast to what happened when 
a contact allergen was applied to normal skin, application of 
contact allergens to the UV-irradiated, LC-depleted skin resulted 
in no induction of contact hypersensitivity. This unresponsiveness 
did not simply reflect a null event, because the UV -irradiated mice 
did not respond to a second application of the same hapten, 
suggesting active immune suppression. Furthermore, antigen­
specific suppressor T cells were found in the spleens of the ' 
UV-irradiated animals [6]. Data from these experiments suggested 
that UVR altered the function of LC so that a tolerance-inducing 
signal rather than an activation signal was sent to the immune 
system. . 
Additional observations supported the hypothesis that the UV­
induced alteration of LC function activated the suppressive path­
way. Cruz and colleagues obtained a relatively pure population of 
LC by sorting out the I-A + epidermal cells [7]. These cells were 
exposed to UVR and conjugated with hapten in vitro. Injecting the 
UV-irradiated LC into mice prevented the subsequent ind\lction of 
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contact hypersensitivity (CHS) when the animals were sensitized 
with hapten. Furthermore, it was discovered that the UV -irradiated 
cells transmitted a tolerance-inducing signal to the immune re­
sponse because the animals did no.t respond to a second application 
of the same hapten. 
Subsequent data reported by Simon and colleagues [8,9] further 
supported the hypothesis that UVR alters LC APC function and 
promotes the induction of T-cell tolerance. PI these experiments 
the ability of UV -irradiated LC to present antigen to two different 
types ofT-cell clones was measured. Two subsets of helper T ceiIs 
have recently been described in mice [10] and humans [11]. These 
cells are distinguished primarily on the cytokines they produce and 
the type of immune responses they participate in. Upon activation, 
T helper 1 cells (Thl) secrete interleukin (lL)-2, 1L-12, and 
interferon gamma (IFN-y); help cell-mediated immune reactions 
(DTH, CHS, CTL, and NK cell activation); and generally help B 
cells produce complement fixing antibodies (lgG2a and IgG3). T 
helper 2 (Th2) cells, on the other hand, secrete IL-4, 5, 6, and 10, 
favor the production of non-complement fixing antibodies (lgGl), 
and are involved with reactions associated with allergy (1gB release, 
activation of mast cells and eosinophils). In addition, the cytokines 
pro.duced by each Th subset can regulate the activity of the other. 
For example, the IL-12 and IFN-y produced by Thl cells can 
down-regulate the proliferation and differentiation of Th2 cells 
[12], and the IL-10 produced by Th2 cells can inhibit IFN-y 
production by Thl cells [10]. Although normal LC present antigen 
to both Thl and Th2 cells, Simon et al discovered that UV­
irradiated LC were unable to present antigen to Thl cells but did 
retain their capacity to present antigen to Th2 cells [8]. In addition, 
it was reported that when UV -irradiated LC were used as APC, not 
only were the Thl cells non-responsive, they were tolerized. This 
tolerant state was associated with functional inactivation of the Thl 
cells rather than deletion, hence clonal anergy. Thus, these studies 
support the hypothesis that UVR triggers immune unresponsive­
ness by altering APC function and point to the epidermal LC as a 
primary target of UVR in the skin. 
It is also clear, however, that modulation ofLC function is not 
the only mechanism by which UVR alters epidermal APC function . 
As in mice, exposing human skin to UVR depletes epidermal LC. 
However, in human skin a population .of inflammatory cells 
migrates into the epidermis after UV exposure [13,14]. These 
CDla -DR + macrophages have been shown to preferentially acti­
vate a population of suppressor-inducer CD4 + T cells and induce 
tolerance [15]. The suppressive activity of these cells may be a 
function of the cytokines they release. Recently, Kang et al 
examined IL-I0 production by the CDla -DR + inflammatory mac­
rophages. At 72 h post irradiation, IL-I0 mRNA expression was 
upregulated and the inflammatory macrophages secreted IL-I0 into 
the culture medium. The authors postulate that these cells migrate 
to the draining lymph nodes, secrete IL-I0, and activate immune 
suppression [16]. Of interest was the finding that although IL-I0 
mRNA was upregulated in UV -irradiated keratinocytes, no protein 
was secreted by these cells, which differs from the situation 
described after irradiation of murine keratinocytes [17] (see below). 
One presumption from the above-mentioned studies, which 
mainly relied on. in vitro techniques, is that UV -damaged LC, or 
UV-induced inflammatory macrophages, encounter antigen in the 
skin, migrate to the draining lymph node, and in the draining lymph 
node send a tolerance-inducing signal to the immune system. To 
determine whether this is indeed the case, Kripke and colleagues 
have employed an in vivo system in which mice are sensitized with 
fluorescein isothyocyanate (FITC) on the shaved ventral skin and 
FITC+ APC are recovered from the draining lymph nodes 18 h 
later. The function of these cells is assessed by determining their 
ability to induce CHS in normal recipient mice. The APCs that 
induce CHS are dendritic in morphology, surface I-A +, and 
radioresistant [18]. Moreover, some of these cells appear to be 
derived from epidermal LC, based on the presence of Birbeck 
granules in their cytoplasm [5]. These cells migrate to the lymph 
node from the skin, form clusters with reactive T cells, and 
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stimulate CHS [19]. However, when the FITC+ dendritic draining 
lymph node cells are isolated from mice sensitized through UV­
irradiated skin and injected into normal recipient mice, CHS is 
depressed and hapten-specific suppressor T cells are activated [18]. 
Comparison of the ultrastructural and phenotypic properties of the 
draining lymph node cells from UV -irradiated or normal mice 
demonstrated several important differences. A significantly greater 
proportion ofFITC+ cells from the UV-irradiated mice expressed 
the macrophage markers, Mac-l, -2, and -3 and F4/80, and there 
were more I-A + cells in the draining lymph nodes ofUV-irradiated 
animals. In addition, fewer dendritic lymph node cells isolated from 
UV -irradiated mice contained Birbeck granules. Kripke and col­
leagues suggest that. the inability of draining lymph node cells to 
present antigen caunot be attributed to a reduction in MHC class II 
expression on the dendritic cells or to fewer numbers of antigen­
bearing cells migrating to the lymph nodes. They suggest that the 
increased numbers of inflammatory cells in the lymph no.des is 
consistent with the data presented by Cooper and colleagues [14] 
and propose that different populations of antigen-bearing cells 
reach the lymph nodes following UV exposure, which may account 
for the induction of tolerance [20]. 
Effects of UVR on APC Populations in the Skin: Role of 
UV -Induced Epidennal Cytokines In addition to the direct 
effects of UVR on APC in the epidermis, UV exposure activates 
keratinocytes to secrete a wide variety of cytokines [21], many of 
which have been shown to modulate APC function. One such 
cytokine is tumor necrosis factor alpha (TNF-a). Extensive studies 
by Streilein and colleagues have pointed out an essential ro.le fo.r 
TNF-a in the inductio.n o.f immune suppressio.n following UVR 
[22] . Inbred strains o.fmice can be catego.rized acco.rding to. the 
effects ofUVR on CHS. UVB-susceptible (UVB-S) strains o.f mice 
are tho.se mice in which CHS fails to. develo.p follo.wing hapten 
sensitization thro.ugh UV -irradiated skin, whereas in UVB-resistant 
mice (UVB-R), CRS develo.ps no.rmally when hapten is applied to 
the UV -irradiated skin. TNF-a appears to play a ro.le in the UVB-S 
pheno.type because injecting UVB-S mice with antibo.dies to. 
TNF-a will co.nvert them fro.m non-responders to. responders [23]. 
Genetic diiferences in the Tnfa lo.cus have been proposed to. 
regulate UVB resistance o.r susceptibility. Specifically, a unique 
mini-repeat in the 5' regulatory region of the Tnfa gene ofUVB-R 
mice has been suggested to interfere with transcription of the gene, 
thus conferring resistance. This micro-satellite is missing in UVB-S 
mice; hence, they produce TNF-a in response to. UVR, and CHS 
is suppressed [24]. 
TNF-a aifects epidermal LC function. Within 1-2 min of 
intracutaneous injection ofTNF, LC withdraw their dendrites and 
become globular in appearance. These morphologic alterations 
appear to correlate with a transient delay in the ability of the treated 
LC to migrate to the regional lymph nodes [25]. Streilein and 
colleagues suggest that intracutaneous production ofTNF alters the 
cytoskeleton of the LC, which modulates their migratory capacity, 
at least transiently, and prevents movement from the skin to the 
draining lymph node, thus interfering with the stimulation ofT-cell 
immunity. It should be noted, however, that this interpretation is 
open to question because studies reported by Moo.dycliJfe et al failed 
to confirm the inhibition of dendritic cell migration by UVR [26]. 
IL-10 is annther cytokine produced by activated keratino.cytes 
[17,27] that aifects APC function [28]. IL-I0, which is found as a 
35-40-kDa homodimer in nature, is produced by T cells, B cells, 
mast cells, macrophages/monocytes, and keratinocytes. IL-tO was 
originally called cytokine synthesis inhibitory factor because of its 
ability to inhibit IFN-y production by Tht clones. IL-I0 suppresses 
T-cell IFN -y production by blocking the ability of APC to present 
the antigen to Thl cells [28] . In addition, IL-I0 has been shown to 
inhibit the production of a variety of other cytokines (lL-l{3, 
TNF-a, granulocyte/macrophage colony-stimulating factor (GM­
CSF) , granulocyte colony-stimulating factor) by macrophages/ 
mono.cytes [29] and interferes with the upregulatio.n of the co.­
stimulato.ry mo.lecule B7/BB1 on APC [30]. 
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Although the exact molecular mechanism through which IL-10 
blocks cytokine synthesis is not known, recent studies suggest that 
IL-10 treatment affects the stability of target inRNA. Kasama et al 
examined the affects of IL-10 on the secretion of IL-8 and 
macrophage infiammatory protein-alpha and -beta (MIP-a, MIP-f3) 
by lipopolysaccharide (LPS)-treated neutrophils. They observed 
that the inhibition of chemokine secretion by lL-l0 was associated 
with an accelerated decay in the half-life of IL-S, MIP-a, and 
MIP-f3 niRNA [31]. Furthermore, although IL-10 suppresses the 
release ofIL-S, IL-1f3, TNF-a, and MIP-a and f3 by LPS-activated 
neutrophils, the production ofIL-l receptor antagonist (IL-1ra) is 
increased after lL-l0 treatment. Cassatella et al report that increased 
synthesis ofIL-l ra is associated with prolongation of the half-life of 
IL-lra niRNA [32]. Thus, it appears that IL-10 alters cytokine 
synthesis by modulating niRNA stability. 
A role for IL-10 in the inhibition of APC function following UV 
exposure has been suggested by Enk et al [33]. Whereas uutreated 
and IL-I0 pretreated LC presented antigen to Th2 clones, IL-l0 
pretreatment abolished the ability ofLC to present to Thl clones. 
The effect ofIL-10 could not be attributed to a down-regulation of 
MHC class IT antigen on the LC, but the introduction of uutreated 
allogeneic LC restored the proliferation of the Th1 cells, suggesting 
that IL-l0 is interfering with a co-stimulatory signal required for 
Thl proliferation. Furthermore, IL-l0-treated LC tolerize Thl 
cells. This was discovered in experiments where T cells, cultured 
with IL-10-treated LC, were rescued and then restimulated with 
fresh LC and antigen. Whereas T cells isolated from control 
cultures responded to antigenic restimulation, those cells that were 
originally cultured with IL-I0-treated LC did not respond to 
antigen. Because all the anergic T cells did proliferate when 
cultured with IL-2, the authors suggest that IL-l0 pretreatment 
alters LC so that they induce clonal anergy in Thl cells. In light of 
the fact that Rivas and Ullrich previously demonstrated that 
UV-irradiated keratinocytes secrete IL-I0 [17], it is possible that 
the UV-induced inhibition ofLC APC function in vivo may be due 
to the release of keratinocyte-derived IL-l0. 
UV-induced keratinocyte IL-l0 can also have systemic effects. It 
has been known for quite some time that spleen cells from 
UV -irradiated mice were deficient in their ability to present antigen 
to T cells [34]. Although direct irradiation of APC by UVR 
efficiendy inhibits APC function (see above), the limited ability of 
UVR to penetrate beyond the dermal-epidermal junction suggests 
that an indirect mechanism is involved in the in vivo impairment of 
splenic APC function. Because UV-irradiated keratinocytes release 
IL-I0, we measured the ability ofIL-l0 to modulate splenicAPC 
function in UV-irradiated mice [35]. Splenic adherent cells were 
Isolated from normal mice, animals exposed to UVR. mice exposed 
to UVR and injected with monoclonal anti-IL-I0, or mice exposed 
to UV and injected with control antibody. These cells were then 
used to present antigen to T-cell clones. Spleen cells from UV­
irradiated mice were not able to efficiently present antigen to '!'h1 
cells, and injecting the UV-irradiated mice with anti-IL-10 anti­
body completely restored the effect. Similarly, when splenic adher­
ent cells were isolated from mice �ected with recombinant IL-10, 
their ability to present antigen was significantly depressed. We also 
measured the effect that UVR had on antigen presentation to Th2 
clones. Compared to the response observed when spleen cells were 
isolated from non-irradiated control mice, exposing Mice to UVR 
resulted in an enhanced ability of their spleen cens to present 
antigen to Th2 cells. Moreover, injecting these mice with annDod­
ies to IL-10 reversed this effect. Thus, these findings suggest that 
keratinocyte-derived IL-I0 is involved in the systemic impairment 
of splenic APC function found in UV -irradiated mice. Further­
more, these observations suggest that one effect of keratinocyte­
derived IL-l0 is to systemically alter APC activity so that presen­
tation to Th1 clones is suppressed, whereas presentation to Th2 
clones is enhanced in UV -irradiated mice. 
Previously, we demonstrated that the suppressor cells induced by 
UV exposure that regulate delayed-type hypersensitivity (DTH) are 
CD3+, CD4+, and CDS- 136,371. Because keratinocyte-derived 
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IL-IO promotes the activation of Th2 clones, we wished to 
detennine whether the UV -induced CD4 + suppressor cells are 
Th2-like cells that inhibit: DTH by the release of cytokines, such as 
IL-4 and IL-I0. To examine this question the fullowing experi­
ments were performed. Suppressor cells were induced in donor 
mice that were exposed to UVR and transferred into normal 
syngeneic recipient mice. These mice were then immunized with 
antigen and divided into four groups. One group received no 
further treatment, the second was �ected with antibodies to IL-4, 
the third with antibodies to IL-l0, and the fourth received control 
antiserum. As demonstrated previousiy, transferring suppressor 
cells from UV -irradiated mice into the recipients suppressed the 
induction of DTH. Injecting these mice with control antibody did 
not interfere with the transfer of suppression. When the recipient 
mice that received the UV-induced suppressor cells were injected 
with annDodies to IL-4 or IL-I0, however, all suppressive activity 
was abrogated. When anti-IL-4 or anti-IL-10 was injected into' 
recipient mice that were transferred with normal T cells, no adverse 
effect was noted, as the DTH response in these animals was 
comparable to that seen in the positive controls. From these 
findings we conclude that the suppressoJ; cells induced following 
UV radiation mediate their immunosuppressive effect through the 
release of IL-10 and IL-4, supporting the hypothesis that the 
UV-induced suppressor cells are Th-2-Hke cells [38]. 
These observations may help clarify some of the "phenomenol­
ogy" of systemic immune suppression that occurs after UV expo­
sure. First. the target ofUV radiation is the skin and, because most 
of the UV radiation is absorbed by the upper layers of skin, an 
indirect mechanism, such as the release of IL-l 0 by keratinocytes, 
is a likely explanation [17]. Second, a systemic impairment of APC 
function is associated with the systemic suppression of DTH 
[34.39]. Our receut findings suggested that this defect in APC 
function is caused by IL-10 [35], which presumably is released by 
UV -irradiated keratinocytes. Third, the phenotype of the suppres­
sor cells (CD3+, CD4+, CDS-) is consistent with the phenotype of 
Th2 cells. The antigen-specificity of the suppressor cells [40,41] can 
also be explained by this model. When the cells are transferred into 
recipient mice that are immunized with the same antigen as the 
donor, the transferred cells are activated, produce IL-4 and IL-I0, 
and suppress the induction ofDTH. But when the suppressor cells 
are transferred to recipient mice that are then immunized with a 
third-party antigen, the transferred cells are not activated, do not 
produce IL-4 and IL-10, and do not suppress. Studies are currently 
in progress to determine whether the UV -induced suppressor cells 
that control the development of tumors in UV -irradiated animals 
also mediate their immunosuppressive effects by the release ofIL-4 
and IL-I0. 
Urocanic acid, a deamination product of histidine , is abundant in 
the upper layers of the epidermis. Upon exposure to UVR, 
urocanic acid is isomerized from the trans- to the cis-isomer. I t  has 
been suggested by De Fabo and Noonan [42] that urocanic acid is 
the photoreceptor in the epidermis, and data from a number of 
laboratories have documented an immunosuppressive role for 
cis-urocanic acid [43]. Cis-urocanic acid also appears to mediate its 
immunosuppressive effects by altering APC function [44]. Noonan 
et al isolated splenic dendritic cells from normal mice, mice exposed 
to UVR, or mice injected intravenously with cis- or trans-urocanic 
acid. These cells were then used to present antigen to primed T 
celis. Injecting mice with 100-200 p.g of cis-, but not trans-, 
urocanic acid significantly depressed the APC function of splenic 
dendritic cells. For the most part, the magnitude of the suppression 
observed following administration of cis-urocanic acid was similar 
to that seen following UV exposure. Modulation of cell-surface 
markers (FcR and MHC class II) or production of suppressive 
fiI.ctors by the splenic dendritic cells could not explain the decreased 
ability of the splenic cells from cis-urocanic acid-injected mice to 
present antigen. 
Cis-urocanic acid also suppresses epidermal LC APCfunction, 
Kurimoto and Streilein [45] observed that intraepidermal injections 
of cis-urocanic acid mimicked the effects of UVR and prevented ' 
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the induction of CHS when the hapten was applied to the treated 
skin. In addition, intradermal injection of cis-urocanic acid de­
creased the density of epidermal LC and altered their morphology. 
It is of interest to note that injectihg anti-TNF-a antibodies 
restored the number of I-A + LC in cis-urocanic acid-treated skin. 
Kurimoto and Streilein suggest that cis-iIrocanic acid is binding to 
receptors on epidermal keratinocytes and inducing the release of 
TNF-a, which is then affecting LC function and morphology. 
Therefore, these findings suggest that cis-urocanic acid, like IL-10, 
interferes with APC function locally at the site of irradiation and 
induces a systemic defect in APC function in the UV -irradiated 
host. 
Modulation of Co-Stimulatory Molecules byUVR As men­
tioned above, co-stimulatory molecules on the surface of APC play 
an important role in T-cell activation . Transfecting cells with the 
genes encoding co-stimulatory molecules, such as intracellular 
adhesion molecule-1 (ICAM-1) [46] or B7 [47], together with 
MHC class II antigens, will promote antigen presentation and/or 
accessory cell function. Alternatively, treating APC with antibodies 
against IcAM-1 will interfere with antigen, mitogen, and anti­
CD3-induced MHC-restricted T-cell proliferation [48,49]. Within 
the epidermis keratinocytes and LC are known to express (either 
constitutively or following induction) ICAM-1 . Moreover, UVRis 
known to modulate the expression of ICAM-1 and hence may 
affect APC function by altering their ability to express co-stimula­
tory molecules [50] . 
To date, although the expression of ICAM-1 on epidermal 
keratinocytes has been studied in some detail, less is known about 
B7 and ICAM-1 expression on LC. Keratinocytes in normal skin or 
long-term cultured keratinocytes do not express ICAM-1 on their 
surface. ICAM-1 expression is up-regulated in situ during inflam­
matory skin disease or after treating keratinocyte cultures with 
cytokines (IFN-y, TNF-a, and TNF-J3) [51,52]. Combinations of 
IFN-y plus TNF-a or lFN-y and TNF-J3 act in a synergistic fashion 
to induce ICAM-1 expression on keratinocytes . The most likely 
source ofTNF-a in vivo are the keratinocytes themselves arid, in all 
probability, the TNF-J3 and IFN-y is produced by infiltrating T 
cells, which by inducing keratinocytes to express ICAM-1 provides 
a target for T-cell LFA-1, thus facilitating and maintaining the 
T-cell infiltrate . 
How does UV light affect ICAM-1 expression? Exposing kera­
tinocytes to UVR inhibits the up-regulation ofiCAM-1 expression 
[51,52]. This occurs in a dose-dependent manner and occurs with 
sublethal doses ofUVR. The effect ofUVR on ICAM-1 expression 
is biphasic. Suppression of cytokine-induced up-regulation of 
ICAM-1 expression was noted 12 h after UVR, but by 48 h ex­
pression ofICAM-1 by keratinocytes was greatly enhanced [51,52]. 
This effect may be related to the production of cytokines by the 
UV-irradiated keratinocytes themselves, because supernatants from 
these cells, collected 48 h after irradiation, up-regulated ICAM-1 
expression when added to non-irradiated keratinocytes [53]. Of 
interest was the observation that treating the supernatants with 
anti-TNF-a antibodies did not abrogate this effect, whereas treat­
ing the supernatants with anti-IL-1a did [50] . 
ICAM-l is also expressed on LC, and antibodies to ICAM-1 can 
interfere with the accessory function of LC . Moreover, UVB 
exposure blocks the up-regulation of ICAM-l normally found 
during in vitro culture of LC [54]. Whether down-regulation of 
ICAM-1 expression in vivo contributes the UVR-induced immune 
suppression is not clear. And although it appears that B7 is 
expressed on cultured human LC [55], and IL-10 has been shown 
to down-regulate the expression ofB7 on human monocytes [56], 
it is not known whether UVR alters the expression of these 
co-stimulatory molecules on LC. 
Effect ofUVR and Epidennal Cytokines on the Induction of 
Tumor Immunity Most of the studies summarized above (in­
cluding our own) have taken the "reductionist approach" to 
studying the role ofUVR in immunity. Break the system down to 
its simplest parts, and study the effect of a limited number of 
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variables on one aspect of immunity. For example, in our studies, 
we have examined the effect that injecting monoclonal anti-IL-10 
has on the UV-induced suppression of DTH, CHS, or systemic 
APC functiou. However, it is clear that the immune system is a 
dynamic, self-regulating system, with a variety of redtmdant control 
mechanisms built in. So, although a reductionist approach is at 
times desirable, and often the only way to dissect complicated 
immunologic pathways, we all must remember that we are at times 
only taking a "snapshot" and not looking at the complete picture. 
One experimental model system that illustrates the dynamic nature 
of the interplay between UV radiation and cytokines on epidermal 
APC function has been described by Granstein and his colleagues 
[57]. In these experiments, I-A + epidermal APC, presumably LC, 
are pulsed with tumor antigen (S1509a cells) and then used to 
immunize mice. The mice are then challenged with viable tumor 
cells, and tumor incidence is measured. It was observed that 
repeated immunization of naive mice with tumor-pulsed, I-A + 
epidermal cells generated protective immunity. The response was 
tumor specific, required immunization with live I-A + cells, and was 
MHC restricted. The capacity of the epidermal I-A + cells to 
present antigen is modulated by a variety of cytokines and envi­
ronmental factors. Pre-incubation of the I-A + epidermal cells with 
GM-CSF, a factor which is known to promote the maturation of 
LC into potent immunostimulatory cells [58], was required for the 
induction of tumor immunity. When GM-CSF treated epidermal 
cells were exposed to UVR prior to antigen pulsing, a UV -dose­
dependent inhibition of tumor immunity was noted . UV exposure 
after antigen pulsing also affected the ability of the epidermal cells 
to present antigen. The effect of treating the epidermal APC with 
TNF-a was also measured. Co-culturing the APCs with GM-CSF 
and TNF-a did not adversely affect the induction of tumor 
immunity. Likewise, incubating the APC with TNF-a prior to 
incubation with GM-CSF did not adversely affect APC function. 
Incubating the epidermal cells with 100 U/ml of TNF-a after 
GM-CSF treatment, on the other hand, did completely abolish the 
induction of tumor immunity. Thus, the timing of TNF-a treat­
ment in regard to GM-CSF exposure is a critical factor in whether 
efficient antigen presentation occurs. Treatment before or at the 
time of GM-CSF administration does not interfere with the matu­
ration signal delivered to the LC but, if TNF-a follows GM-CSF, 
the immunostimulatory activity of the LC is abolished [59]. The 
opposite result is seen when IL-IO is used. Treating the epidermal 
cells with rIL-10 (20 ng/ml) prior to or during GM-CSF exposure 
abolished all APC activity. However, IL-10 treatment after GM­
CSF exposure did not have any adverse affect on the APC function 
[60]. Similarly, treating the epidermal cells with IFN-y during 
GM-CSF exposure inhibited the APC function of the I-A + epider­
mal cells [61]. These results confirm the inhibitory effects ofUVR 
and epidermal-derived cytokines on APC function. Perhaps more 
importantly, however, they point out the dynamic nature of the 
interaction between UVR, UV-induced cytokines, and APC. 
What Is the Photoreceptor in the Skin for UV -Induced 
Immune Suppression? To date, two molecules have been 
suggested as the photoreceptor in the skin that initiates the immune 
suppression caused by UVR. Based on observations that placed the 
location of the photoreceptor in the stratum corneum , and findings 
that demonstrated that the action spectrum for photoimmunosup­
pression closely matched the action spectrum for the isomerization 
of urocanic acid, De Fabo and Noonan suggested that the photo­
receptor for UVR in the skin is trans-urocanic acid. After irradia­
tion with UVB, trans-urocanic acid isomerizes to cis-urocanic acid, 
which then activates the immunosuppressive pathway [42]. Over 
the years, data from a number of laboratories have supported this 
hypothesis by demonstrating the immunosuppressive properties of 
cis-urocanic acid (see above and [43]). Recently, however, data has 
been presented that suggests that the in vivo action spectrum for 
photoisomerization of urocanic acid differs significantly from the 
action spectrum for immune suppression [62]. In addition, Moody­
cliffe et al report that although the broad-band UVB (270-350 nm) 
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from a fluorescent sun lamp did suppress the induction of CHS, 
narrow-band UVB (3 1 1-312  urn) did not, regardless of the fact that 
both light sources caused the photoisomerization of urocanic acid 
[26] . Thus, there is some question as to whether urocanic acid is the 
only photoreceptor in the skin. Studies by Kripke and colleagues 
have suggested that DNA may also serve as the photoreceptor. 
Two experimental approaches were used in these studies. Apple­
gate et al observed that irradiating the marsupial Monodelphis 
domestica with photoreactivating light after UV exposure reversed 
the UV-induced suppression of CHS [63].  Because irradiating M. 
domestica with visible light activates the photoreactivating enzyme 
that repairs pyrimidine dimers [64] , these studies suggest that DNA 
is the photoreceptor. The second approach employed the strategy 
of using liposomes to introduce the bacteriophage excision repair 
enzyme, T4 endonuclease V, into mice [64]. Animals were exposed 
with UVR, and then the liposomes suspended in a Hydrogel 
vehicle were painted onto the skins of the mice. Both the UV­
induced suppression of CHS and DTH was inhibited when the 
enzyme-containing liposomes were applied to the skins of the 
irradiated animals. No inhibition of suppression was observed when 
control liposomes containing a heat-inactivated preparation of 
enzyme were applied to the skin. Moreover, the induction of 
UV -induced suppressor T cells was inhibited when the liposomes 
containing the endonuclease repair enzyme were applied to the skin 
[65] . These findings confirm the data obtained with the marsupials 
and suggest that DNA is the photoreceptor for UV-induced 
immune suppression. It is of interest to note that activating the 
photoreactivating enzyme in situ or using liposomes to introduce 
the excision repair enzyme also interferes with the induction of skin 
cancer by UVR [65,66] .  
SUMMARY, CONCLUSIONS AND QUESTIONS 
FOR THE FUTURE 
It is clear that UVR is an immunosuppressive agent and its ability to 
down-regulate immunity has been linked to its carcinogenic poten­
tial [67,68]. A key elfect of UVR on the immune system is the 
modulation of APC function. UVR alters APC function direcdy by 
a1fecting epidermal LC [7,8] or indirecdy by inducing keratinocytes 
to release immunomodulatory cytokines [33,45]. These cytokines 
appear to work both locally and systemically to alter APC function 
[35,44] . 
Why have redundant mechanisms evolved to suppress the 
immune response after UV exposure? Some have suggested that the 
mutagenic potential of UVR coupled with the need to maintain 
skin homeostasis resulted in the development of these redundant 
suppressive mechanisms. One consequence ofUVR exposure may 
be the development of new or altered skin antigens that the 
immune system recognizes as foreign. The pressure to prevent an 
autoimmune reaction to UV -modified skin antigens may be the 
driving force behind the evolution of UV -triggered immune sup­
pression [1]. 
A common theme found in a number of the studies reviewed 
here is the UV -induced activation of Th2 cells coupled with the 
induction of Th1 cell tolerance [9,33,35] . Because Th1 cells 
generally help cell-mediated immune reactions, such as DTH, 
CHS, and tumor rejection, the suppression of this arm of the 
immune system fits in with the well-described selective suppression 
of immunity after UV exposure [1] . Does this shift from a Thl-like 
response to a Th2-like immune reaction also reflect the pressure to 
avoid anti-skin auto immune reactions, or are other mechanisms 
involved? 
What other immune reactions are regulated by UVR? Animal 
studies from a number of laboratories have clearly shown that UV 
exposure can interfere with the response to and clearance of some 
infectious organisms [69,70] .  Does the UVR found in sunlight play 
any role in susceptibility of humans to infectious agents? And 
although it is acknowledged that ozone depletion will contribute to 
an increased incidence of human skin cancer, will depletion of the 
ozone layer have any a1fect on human susceptibility to infectious 
agents? 
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Table I. Important Questions for Future Research 
• What is the UV photoreceptor-urocanic acid or DNA? 
• Which UV-induced epidennal "cytokine" is essential for the induction 
of immune suppression, IL-l0, TNF-a, IL-l ,  cis-urocanic acid, PGE2, 
or others, as yet undiscovered? Do they work in concert or alone to 
induce immune suppression? 
• Which cell produces UV-induced suppressive cytokines, the keratino­
cyte or the infiltrating macrophage? 
• Does UV-induced immune suppression play a role in the susceptibility 
of humans to infectious agents? 
• How can we effectively limit sun exposure? Are the current generation 
of sunscreens effective at protecting against the immune suppressive 
effects of UV radiation? 
How can we prevent the deleterious immunosuppressive effects 
of UVR? Total avoidance is impractical, and efforts of late have 
been designed to limit sun exposure. Chemical sunscreens are an 
important part of this strategy. Although sunscreens are quite 
effective at preventing sunburn and erythema and are thought to 
protect against the induction of skin cancer by preventing DNA 
damage, it is not clear that they prevent the immunologic damage 
caused by UVR. In studies by Kripke and colleagues, sunscreens 
were very elfective at protecting against the inflammation caused by 
UVR, but only marginally effective at preventing UV -induced 
immune suppression [71 ,72] . Of course, these results must be 
viewed with caution because FS-40 sunlamps, which emit shorter 
wavelengths of UV radiation than solar radiation were employed; 
therefore, extrapolating these results to humans is difficult. These 
findings do indicate the need for more research into the prevention 
of UV-induced immunologic damage by chemical sunscreens. 
Finally, some efforts have been made at ameliorating the immune 
suppressive effects of UVR. Strickland and colleagues found that 
topical application of a gel extract from Aloe barbadensis to murine 
skin after UV exposure can block the induction of immune 
suppression [73]. Similarly, studies from my laboratory have indi­
cated that treating mice systemically with IL-12, which prevents the 
differentiation of Th2 cells [12], after UV exposure blocks the 
induction of immune suppression [74] . Hopefully, in the future it 
may be possible to prevent the induction of immune suppression in 
people who spend a little too much time in the noon-day sun. 
This work was supported by grant AR 40824 from the National Institutes oj' 
Arthritis and Musculoskeletal and Skin Disease. 
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